Physician profile
Christopher Smith Travers
NPI 1588923940
$9,944.91
in general payments reported to CMS, 2019-2025
13 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,567 · 2020: $2,828 · 2021: $1,295 · 2022: $324 · 2023: $195 · 2024: $1,388 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,009 · Food and Beverage: $901 · Education: $21.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,008.54 |
| Food and Beverage | $900.73 |
| Education | $21.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,594.84 | 2019-2021 | |
| Stryker Corporation | $3,331.36 | 2019-2024 | Mako |
| Zimmer Biomet Holdings, INC. | $1,876.36 | 2019-2025 | Persona, Tapestry, Rosa |
| Depuy Synthes Sales INC. | $364.62 | 2019-2020 | |
| Heraeus Medical, LLC. | $200.85 | 2024-2025 | |
| Convatec INC. | $184.10 | 2025 | |
| Intellijoint Surgical INC. | $146.09 | 2019 | |
| Baxter Healthcare | $65.40 | 2024 | Tisseel |
| Smith+Nephew, INC. | $61.70 | 2020-2024 | Pico 7 |
| Biocomposites INC | $50.63 | 2019 | |
| Exactech, INC. | $39.90 | 2019 | |
| Kci USA, INC. | $16.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Travers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.